684 related articles for article (PubMed ID: 26772968)
41. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
42. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
[TBL] [Abstract][Full Text] [Related]
43. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse.
Li B; Stribley JA; Ticu A; Xie W; Schopfer LM; Hammond P; Brimijoin S; Hinrichs SH; Lockridge O
J Neurochem; 2000 Sep; 75(3):1320-31. PubMed ID: 10936216
[TBL] [Abstract][Full Text] [Related]
44. Acetylcholinesterase and butyrylcholinesterase activities in obese Beagle dogs before and after weight loss.
Tvarijonaviciute A; Ceron JJ; Tecles F
Vet Clin Pathol; 2013 Jun; 42(2):207-11. PubMed ID: 23550593
[TBL] [Abstract][Full Text] [Related]
45. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
[TBL] [Abstract][Full Text] [Related]
46. Inhibitory effect of suberogorgin on acetylcholinesterase.
Peng WD; Xu SB; Peng X
Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):369-72. PubMed ID: 9812727
[TBL] [Abstract][Full Text] [Related]
47. Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex.
Albuquerque EX; Aracava Y; Cintra WM; Brossi A; Schönenberger B; Deshpande SS
Braz J Med Biol Res; 1988; 21(6):1173-96. PubMed ID: 3074841
[TBL] [Abstract][Full Text] [Related]
48. Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase.
Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
Bioorg Chem; 2018 Oct; 80():668-673. PubMed ID: 30059892
[TBL] [Abstract][Full Text] [Related]
49. Differential mRNA expression of acetylcholinesterase in the central nervous system of rats with acute and chronic exposure of sarin & physostigmine.
Bansal I; Waghmare CK; Anand T; Gupta AK; Bhattacharya BK
J Appl Toxicol; 2009 Jul; 29(5):386-94. PubMed ID: 19283689
[TBL] [Abstract][Full Text] [Related]
50. Kinetics of human serum butyrylcholinesterase inhibition by a novel experimental Alzheimer therapeutic, dihydrobenzodioxepine cymserine.
Kamal MA; Klein P; Luo W; Li Y; Holloway HW; Tweedie D; Greig NH
Neurochem Res; 2008 May; 33(5):745-53. PubMed ID: 17985237
[TBL] [Abstract][Full Text] [Related]
51. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study.
Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R
Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245
[TBL] [Abstract][Full Text] [Related]
52. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
53. Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine.
Kamal MA; Al-Jafari AA; Yu QS; Greig NH
Biochim Biophys Acta; 2006 Feb; 1760(2):200-6. PubMed ID: 16309845
[TBL] [Abstract][Full Text] [Related]
54. Alkynyl and β-ketophosphonates: Selective and potent butyrylcholinesterase inhibitors.
Cavallaro V; Moglie YF; Murray AP; Radivoy GE
Bioorg Chem; 2018 Apr; 77():420-428. PubMed ID: 29427857
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of acetyl- and butyrylcholinesterase and amylase release from canine pancreas.
Oguchi Y; Dressel TD; Borner JW; Miller J; Goodale RL
Pancreas; 1989; 4(4):423-8. PubMed ID: 2474812
[TBL] [Abstract][Full Text] [Related]
56. Acetylcholinesterase and butyrylcholinesterase are expressed in the spinal meninges of monkeys and pigs.
Ummenhofer WC; Brown SM; Bernards CM
Anesthesiology; 1998 May; 88(5):1259-65. PubMed ID: 9605686
[TBL] [Abstract][Full Text] [Related]
57. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
58. Effects of T-82, a new quinoline derivative, on cholinesterase activity and extracellular acetylcholine concentration in rat brain.
Isoma K; Ishikawa M; Ohta M; Ogawa Y; Hasegawa H; Kohda T; Kamei J
Jpn J Pharmacol; 2002 Feb; 88(2):206-12. PubMed ID: 11928722
[TBL] [Abstract][Full Text] [Related]
59. Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.
Shinada M; Narumi F; Osada Y; Matsumoto K; Yoshida T; Higuchi K; Kawasaki T; Tanaka H; Satoh M
Bioorg Med Chem; 2012 Aug; 20(16):4901-14. PubMed ID: 22831800
[TBL] [Abstract][Full Text] [Related]
60. Polymorphism of pseudocholinesterase in Torpedo marmorata tissues: comparative study of the catalytic and molecular properties of this enzyme with acetylcholinesterase.
Toutant JP; Massoulié J; Bon S
J Neurochem; 1985 Feb; 44(2):580-92. PubMed ID: 2578181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
